⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BJDX News
Bluejay Diagnostics, Inc. Common Stock
Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
globenewswire.com
BJDX
Form 8-K
sec.gov
BJDX
Form 8-K
sec.gov
BJDX
Form 8-K
sec.gov
BJDX
Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting
globenewswire.com
BJDX
Form 8-K
sec.gov
BJDX
Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook
globenewswire.com
BJDX
Form 8-K
sec.gov
BJDX
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
globenewswire.com
BJDX
Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026
globenewswire.com
BJDX